About General Atlantic
General Atlantic is a leading global investor with more than four and a half decades of experience providing capital and strategic support for over 830 companies throughout its history. Established in 1980, General Atlantic continues to be a dedicated partner to visionary founders and investors seeking to build dynamic businesses and create long term value. Guided by the conviction that entrepreneurs can be incredible agents of transformational change, the firm combines a collaborative global approach, sector specific expertise, a long-term investment horizon, and a deep understanding of growth drivers to partner with and scale innovative businesses around the world. The firm leverages its patient capital, operational expertise, and global platform to support a diversified investment platform spanning Growth Equity, Credit, Climate, and Sustainable Infrastructure strategies. General Atlantic manages approximately $123 billion in assets under management, inclusive of all strategies, as of December 31, 2025, with more than 900 professionals in 20 countries across five regions. For more information on General Atlantic, please visit: www.generalatlantic.com.
General Atlantic Life Sciences Practice
The GA Life Sciences practice provides capital and strategic support for development stage biopharma companies, with an established track record across public and private investments. The Life Sciences team focuses on novel therapies that provide substantial patient benefit and have the potential to redefine standards of care. GA’s differentiated approach to life sciences is characterized by highly thematic investing, scaling significant capital into companies as they advance through clinical development and commercialization, and partnering with management teams to generate value. Investments include Akero Therapeutics (acquired by Novo Nordisk), Karuna Therapeutics (acquired by BMS), Cincor Pharma (acquired by AstraZeneca), and Centessa Pharmaceuticals (potential acquisition by Eli Lilly).
Position Summary
General Atlantic is seeking a Life Sciences investor to join our New York‑based investment team. This role will have exposure to all parts of the investment process, including evaluating new investment opportunities and investment themes in biopharma and life science companies, conducting technical diligence, supporting deal execution, and working with portfolio companies. The ideal candidate will have a scientific background (MD or PhD) and at least two years of relevant industry experience, with the goal of driving strategic growth and generating value for the firm’s portfolio.
Responsibilities
- Source, evaluate, and recommend investment opportunities in drug development / biopharmaceutical companies including development and ownership of thematic focus areas
- Support scientific and clinical due diligence, integrating preclinical data, clinical trial results, regulatory strategy, and market dynamics into investment recommendations
- Develop and present rigorous investment theses to senior stakeholders, including the global Investment Committee
- Contribute across the full deal process, including coordination of third-party scientific advisors, KOLs, and commercial consultants
- Monitor portfolio companies and support the GA team’s efforts in capital allocation and value creation
- Leverage clinical and industry networks to generate proprietary deal flow and market intelligence
- Collaborate with professionals across the firm and foster exceptional knowledge-sharing
Qualifications
- MD or PhD in relevant scientific field (molecular biology, genetics, biology, chemistry, etc.)
- 2-5 years of post-graduate school professional experience, including at least 2 years of relevant experience in the life sciences sector (e.g., life sciences investing, life sciences strategy consulting, life sciences equity research / investment banking, biopharma operating role)
- Ability to analyze and integrate data from various sources into investment recommendations, including preclinical and clinical data, FDA/regulatory correspondence, and market research
- Strong foundation in financial modeling with a demonstrated commitment to deepening analytical expertise
- Passion for primary scientific literature, including scientific/medical meetings and conferences
- High degree of familiarity with drug development and regulatory processes
- Excellent written and verbal communication skills, with the ability to synthesize and present complex information clearly
- Demonstrated maturity and professional presence; comfortable interacting with senior executives and management teams
- Highly motivated, inquisitive, and a positive, can-do attitude
- Ability to take ownership, work independently, manage multiple priorities, and thrive in a fast-paced, entrepreneurial environment
GA Value
General Atlantic offers a robust reward program to all employees that will support you and your family, maintaining fulfilling, secure and healthy lives now and into the future, which includes but is not limited to medical insurance, retirement savings contributions, mental and physical health resources and an equal pay program that allows you to earn a base salary of $150,000 –160,000 of which the exact amount offered will be driven by the degree to which you meet role requirements, additional special skills and experience. Additional reward programs, such as annual discretionary bonuses and long-term incentive programs, are available for eligible employees and are offered as recognition for performance and one’s contributions towards the organization’s success.
General Atlantic is an equal opportunity employer and does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
By completing this application, you are consenting to General Atlantic’s processing and use of your personal data. Information on how General Atlantic will use and process your data can be found here: https://www.generalatlantic.com/privacy-notice/